122
Participants
Start Date
July 13, 2020
Primary Completion Date
December 2, 2021
Study Completion Date
May 30, 2022
MDI
Subject continues their standard Multiple Daily Injections therapy with FGM or RT-CGM
AHCL
"Subject starts using the Advance Hybrid Close Loop (AHCL) MiniMed™ 670G system version 4.0.~Starting time depends on which Arm the subject is assigned to: if the subject is assigned to the Treatment Arm, then the intervention starts after the RUN-IN period. If the subject is assigned to the Control Arm the intervention will start after 6 months from the date of the enrollment."
Centre Hospitalier Universitaire Besancon - Hôpital Jean Minjoz, Besançon
CHU de Bordeaux - Hôpital Saint André, Bordeaux
CHU Caen, Caen
Hospices Civils de Lyon (DIAB-e CARE), Lyon
APM - Hôpital de la Conception, Marseille
Hospital Civil, Strasbourg
Diabetologische Schwerpunktpraxis Dr. Ralf Kolassa, Bergheim
Zentrum für Diabetologie Bergedorf, Hamburg
Gemeinschaftspraxis im Westtor Hausarztpraxis & Diabetologische Schwerpunktpraxis, Lage
Medical Center am Clemenshospital Dr. Winfried Keuthage, Münster
Cambridge University Hospitals NHS Foundation Trust - Addenbrooke's Hospital, Cambridge
Harrogate and District Hospital - NHS Foundation Trust, Harrogate
University Hospitals of Leicester NHS Trust Leicester General Hospital, Leicester
King's College Hospital NHS Foundation Trust, London
Medtronic Diabetes
INDUSTRY